246 related articles for article (PubMed ID: 3698338)
1. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
Kerr MA; Wilton E; Naama JK; Whaley K
Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
Naama JK; Mitchell WS; Whaley K
Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
4. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
5. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
6. IgM-RF prevents complement-mediated inhibition of immune precipitation.
Mitchell WS; Naama JK; Veitch J; Whaley K
Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
[TBL] [Abstract][Full Text] [Related]
7. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K
Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
[TBL] [Abstract][Full Text] [Related]
8. Serial circulating immune complexes and mononuclear phagocyte system function in infective endocarditis.
Schned ES; Inman RD; Parris TM; Kimberly RP; Redecha PB; Christian CL
J Lab Clin Med; 1983 Dec; 102(6):947-59. PubMed ID: 6227674
[TBL] [Abstract][Full Text] [Related]
9. Reduced complement-mediated immune complex solubilization in leprosy patients.
Ramanathan VD; Sharma P; Ramu G; Sengupta U
Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
[TBL] [Abstract][Full Text] [Related]
10. Serum and tissue immune complexes in infective endocarditis.
McKenzie PE; Hawke D; Woodroffe AJ; Thompson AJ; Seymour AE; Clarkson AR
J Clin Lab Immunol; 1980 Nov; 4(3):125-32. PubMed ID: 7205936
[TBL] [Abstract][Full Text] [Related]
11. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy.
Schena PF; Pastore A; Sinico RA; Montinaro V; Fornasieri A
J Immunol; 1988 Jul; 141(1):125-30. PubMed ID: 3379302
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.
Reynolds WJ; Yoon SJ; Emin M; Chapman KR; Klein MH
J Rheumatol; 1986 Aug; 13(4):700-6. PubMed ID: 3490573
[TBL] [Abstract][Full Text] [Related]
13. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
14. Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.
Schifferli JA; Steiger G; Hauptmann G; Spaeth PJ; Sjöholm AG
J Clin Invest; 1985 Dec; 76(6):2127-33. PubMed ID: 2934406
[TBL] [Abstract][Full Text] [Related]
15. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
[TBL] [Abstract][Full Text] [Related]
16. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
Balestrieri G; Pagani D; Tincani A
J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in patients with IgA glomerulonephritis.
Nagy J; Füst G; Ambrus M; Trinn C; Paál M; Burger T
Acta Med Acad Sci Hung; 1982; 39(3-4):211-8. PubMed ID: 6985242
[TBL] [Abstract][Full Text] [Related]
18. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
Schifferli JA; Morris SM; Dash A; Peters DK
Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in infective endocarditis.
Bayer AS; Theofilopoulos AN; Eisenberg R; Dixon FJ; Guze LB
N Engl J Med; 1976 Dec; 295(27):1500-5. PubMed ID: 995157
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria.
Jhaveri KN; Ghosh K; Mohanty D; Parmar BD; Surati RR; Camoens HM; Joshi SH; Iyer YS; Desai A; Badakere SS
Natl Med J India; 1997; 10(1):5-7. PubMed ID: 9069696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]